Related references
Note: Only part of the references are listed.Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies
Iain Abbott et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative Pathogens
Olympia Zarkotou et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Carbapenem Susceptibility Testing Errors Using Three Automated Systems, Disk Diffusion, Etest, and Broth Microdilution and Carbapenem Resistance Genes in Isolates of Acinetobacter baumannii-calcoaceticus Complex
Ana Elizabeth Markelz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Nosocomial bacteraemia: the most neglected causes of death in Europe?
D. Raoult et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Acinetobacter baumannii resistant to everything: what should we do?
J. Vila et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Dafna Yahav et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals
Steven J. Nigro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India
Neeraj Goel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
Federico Perez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii
Eliahu Bishburg et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial
A. C. Rodloff et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study
Dimitrios K. Matthaiou et al.
CRITICAL CARE MEDICINE (2008)
Acinetobacter baumannii:: a universal threat to public health?
Helen Giamarellou et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections:: a review of the scientific evidence
Drosos E. Karageorgopoulos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
Drosos E. Karageorgopoulos et al.
LANCET INFECTIOUS DISEASES (2008)
Current concepts: Acinetobacter infection
L. Silvia Munoz-Price et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
Shiri Navon-Venezia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals
Maria Souli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002)
DJ Biedenbach et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
